Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failure

25 Nov 2020

Abstract excerpt

The use of mesenchymal stem cells (MSC) derived from several sources has been suggested as a major anti-inflammation strategy during the recent outbreak of coronavirus-19 (COVID-19). As the virus enters the target cells through the receptor ACE2, it is important to determine if the MSC population transfused to patients could also be a target for the virus entry. We report here that ACE2 is highly expressed in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ethics and Legal Issues in Pediatric Healthcare
Share to Mesenchymal stem cell research
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33237619
DOI: 10.1002/sctm.20-0189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19-associated organ failurePMID 33237619Read ↗

Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cellsSemantic proximity Read ↗

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.Semantic proximity Read ↗

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read ↗

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read ↗

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSCSemantic proximity Read ↗

Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signatureSemantic proximity Read ↗

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 InflammasomeSemantic proximity Read ↗

Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue RegenerationSemantic proximity Read ↗

MSCs vs. iPSCs: Potential in therapeutic applicationsSemantic proximity Read ↗

Mesenchymal Stem Cells Impact on COVID-19 Patients Immune System, an Ex Vivo StudySemantic proximity Read ↗

The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responsesSemantic proximity Read ↗

Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profilingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.